TY - JOUR
T1 - Prolonged Wireless pH Monitoring in Patients With Persistent Reflux Symptoms Despite Proton Pump Inhibitor Therapy
AU - Hasak, Stephen
AU - Yadlapati, Rena
AU - Altayar, Osama
AU - Sweis, Rami
AU - Tucker, Emily
AU - Knowles, Kevin
AU - Fox, Mark
AU - Pandolfino, John
AU - Gyawali, C. Prakash
N1 - Funding Information:
Funding This study was partially funded through National Institutes of Health/National Institute for Diabetes and Digestive and Kidney Diseases (T32 DK007130 [to Stephen Hasak], P30DK052574 [to Stephen Hasak], T32DK101363 [to Rena Yadlapati], R01: DK092217 [to John Pandolfino]). Conflicts of interest These authors disclose the following: Rena Yadlapati has served as a consultant for Medtronic, Ironwood Pharmaceuticals, and Diversatek. Rami Sweis has received educational grant support from Medtronic. Mark Fox has received research and/or educational grant support from Medtronic, Diversatek, and Laborie; and has served as a consultant for Mui Scientific and Reckitt Benckiser. John Pandolfino has served as a consultant for Medtronic, Diversatek, Torax, Ironwood, Takeda, and AstraZeneca; has received research support from Impleo; and owns stock options with Crospon. C. Prakash Gyawali has served as a consultant for Medtronic, Diversatek, Torax, Ironwood, Isothrive, and Quintiles; and as a speaker for Medtronic and Diversatek. The remaining authors disclose no conflicts.
Funding Information:
Conflicts of interest These authors disclose the following: Rena Yadlapati has served as a consultant for Medtronic, Ironwood Pharmaceuticals, and Diversatek. Rami Sweis has received educational grant support from Medtronic. Mark Fox has received research and/or educational grant support from Medtronic, Diversatek, and Laborie; and has served as a consultant for Mui Scientific and Reckitt Benckiser. John Pandolfino has served as a consultant for Medtronic, Diversatek, Torax, Ironwood, Takeda, and AstraZeneca; has received research support from Impleo; and owns stock options with Crospon. C. Prakash Gyawali has served as a consultant for Medtronic, Diversatek, Torax, Ironwood, Isothrive, and Quintiles; and as a speaker for Medtronic and Diversatek. The remaining authors disclose no conflicts.
Funding Information:
Funding This study was partially funded through National Institutes of Health / National Institute for Diabetes and Digestive and Kidney Diseases ( T32 DK007130 [to Stephen Hasak], P30DK052574 [to Stephen Hasak], T32DK101363 [to Rena Yadlapati], R01: DK092217 [to John Pandolfino]).
Publisher Copyright:
© 2020 AGA Institute
PY - 2020/12
Y1 - 2020/12
N2 - Background & Aims: Wireless pH monitoring measures esophageal acid exposure time (AET) for up to 96 hours. We evaluated competing methods of analysis of wireless pH data. Methods: Adult patients with persisting reflux symptoms despite acid suppression (n = 322, 48.5 ± 0.9 years, 61.7% women) from 2 tertiary centers were evaluated using symptom questionnaires and wireless pH monitoring off therapy, from November 2013 through September 2017; 30 healthy adults (control subjects; 26.9 ± 1.5 years; 60.0% women) were similarly evaluated. Concordance of daily AET (physiologic <4%, borderline 4%–6%, pathologic>6%) for 2 or more days constituted the predominant AET pattern. Each predominant pattern (physiologic, borderline, or pathologic) in relation to data from the first day, and total averaged AET, were compared with other interpretation paradigms (first 2 days, best day, or worst day) and with symptoms. Results: At least 2 days of AET data were available from 96.9% of patients, 3 days from 90.7%, and 4 days from 72.7%. A higher proportion of patients had a predominant pathologic pattern (31.4%) than control subjects (11.1%; P = .03). When 3 or more days of data were available, 90.4% of patients had a predominant AET pattern; when 2 days of data were available, 64.1% had a predominant AET pattern (P < .001). Day 1 AET was discordant with the predominant pattern in 22.4% of patients and was less strongly associated with the predominant pattern compared with 48 hour AET (P = .059) or total averaged AET (P = .02). Baseline symptom burden was higher in patients with a predominant pathologic pattern compared with a predominant physiologic pattern (P = .02). Conclusions: The predominant AET pattern on prolonged wireless pH monitoring can identify patients at risk for reflux symptoms and provides gains over 24 hours and 48 hours recording, especially when results from the first 2 days are discordant or borderline.
AB - Background & Aims: Wireless pH monitoring measures esophageal acid exposure time (AET) for up to 96 hours. We evaluated competing methods of analysis of wireless pH data. Methods: Adult patients with persisting reflux symptoms despite acid suppression (n = 322, 48.5 ± 0.9 years, 61.7% women) from 2 tertiary centers were evaluated using symptom questionnaires and wireless pH monitoring off therapy, from November 2013 through September 2017; 30 healthy adults (control subjects; 26.9 ± 1.5 years; 60.0% women) were similarly evaluated. Concordance of daily AET (physiologic <4%, borderline 4%–6%, pathologic>6%) for 2 or more days constituted the predominant AET pattern. Each predominant pattern (physiologic, borderline, or pathologic) in relation to data from the first day, and total averaged AET, were compared with other interpretation paradigms (first 2 days, best day, or worst day) and with symptoms. Results: At least 2 days of AET data were available from 96.9% of patients, 3 days from 90.7%, and 4 days from 72.7%. A higher proportion of patients had a predominant pathologic pattern (31.4%) than control subjects (11.1%; P = .03). When 3 or more days of data were available, 90.4% of patients had a predominant AET pattern; when 2 days of data were available, 64.1% had a predominant AET pattern (P < .001). Day 1 AET was discordant with the predominant pattern in 22.4% of patients and was less strongly associated with the predominant pattern compared with 48 hour AET (P = .059) or total averaged AET (P = .02). Baseline symptom burden was higher in patients with a predominant pathologic pattern compared with a predominant physiologic pattern (P = .02). Conclusions: The predominant AET pattern on prolonged wireless pH monitoring can identify patients at risk for reflux symptoms and provides gains over 24 hours and 48 hours recording, especially when results from the first 2 days are discordant or borderline.
KW - Diagnostic
KW - GERD
KW - Gastroesophageal Reflux Disease
KW - Prognostic
UR - http://www.scopus.com/inward/record.url?scp=85092015039&partnerID=8YFLogxK
U2 - 10.1016/j.cgh.2020.01.031
DO - 10.1016/j.cgh.2020.01.031
M3 - Article
C2 - 32007543
AN - SCOPUS:85092015039
SN - 1542-3565
VL - 18
SP - 2912
EP - 2919
JO - Clinical Gastroenterology and Hepatology
JF - Clinical Gastroenterology and Hepatology
IS - 13
ER -